OTC Serialization is now also a topic

Pharmaceutical companies specializing in the production of over-the-counter drugs (OTC) have not been affected by pharmaceutical serialization so far. This is now changing for companies that are also active on the Russian market. The serialization requirements in Russia are much more complex than those of the EU-FMD. The so-called EU Counterfeiting Directive has been in […]

Read More… from OTC Serialization is now also a topic


Crypto-Code and language barriers: Serialization in Russia and China

The implementation of EU-FMD  is not the only track&trace initiative to protect against counterfeit medicines. Many projects around the world are more or less based on similar standards but are all aimed at protecting patients and making supply chains counterfeit-proof. I.e. Russian Crypto-Codes and the serialization requirements in China. Russia and China are two countries […]

Read More… from Crypto-Code and language barriers: Serialization in Russia and China


Pilot phase of our new product: HX Secur – Data delivery for hospitals made easy

Several weeks have already passed since the FMD came into force. The implementation of the directive poses a major challenge, especially for hospital pharmacies. Nevertheless, a practicable solution has not yet been found. Logistics experts and manufacturers have recently been asked to offer special hospital deliveries. Now tracekey provides them a solution – HX Secur […]

Read More… from Pilot phase of our new product: HX Secur – Data delivery for hospitals made easy


Brexit: Pharmaceutical industry particularly affected by No-Deal Brexit

The day of the Brexit – March 29 – is slowly approaching and there is still no regulated withdrawal insight. The pharmaceutical industry would be particularly affected by hard Brexit. Without regulated conditions and joint agreements, a complex situation would arise for the chemical and pharmaceutical industries, which could even lead to supply bottlenecks. A […]

Read More… from Brexit: Pharmaceutical industry particularly affected by No-Deal Brexit


Interim results: Eleven days after the FMD deadline, the mood is mixed, many countries are making a soft start

Eleven days after the deadline for the implementation of the Falsified Medicines Directive (FMD), the first interim results are rather mixed. Many pharmacies in the UK and France are not connected at all, and in Germany, they are demanding that the additional costs be borne. The mood in Europe is very mixed just two weeks […]

Read More… from Interim results: Eleven days after the FMD deadline, the mood is mixed, many countries are making a soft start